Phase II trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and intensity moduled radiation therapy (IMRT) for locally advanced head and neck cancer

被引：0
|
作者：
Kao, J. [1 ]
Policarpio, L. [1 ]
Teng, M. [1 ]
Burri, R. [1 ]
Genden, E. [1 ]
Packer, S. [1 ]
机构：
[1] Mt Sinai Sch Med, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6014
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer
    Ferris, Robert L.
    Moskovitz, Jessica
    Kunning, Sheryl
    Ruffin, Ayana T.
    Reeder, Carly
    Ohr, James
    Gooding, William E.
    Kim, Seungwon
    Karlovits, Brian J.
    Vignali, Dario A. A.
    Duvvuri, Umamaheswar
    Johnson, Jonas T.
    Petro, Daniel
    Heron, Dwight E.
    Clump, David A.
    Bruno, Tullia C.
    Bauman, Julie E.
    CLINICAL CANCER RESEARCH, 2022, 28 (07) : 1335 - 1344
  • [42] Phase I/II study of daily carboplatin, 5-fluorouracil and concurrent radiation therapy for locally advanced non-small-cell lung cancer
    Yoshizawa, H
    Tanaka, J
    Kagamu, H
    Maruyama, Y
    Miyao, H
    Ito, K
    Sato, T
    Iwashima, A
    Suzuki, E
    Gejyo, F
    BRITISH JOURNAL OF CANCER, 2003, 89 (05) : 803 - 807
  • [43] Phase I/II study of daily carboplatin, 5-fluorouracil and concurrent radiation therapy for locally advanced non-small-cell lung cancer
    H Yoshizawa
    J Tanaka
    H Kagamu
    Y Maruyama
    H Miyao
    K Ito
    T Sato
    A Iwashima
    E Suzuki
    F Gejyo
    British Journal of Cancer, 2003, 89 : 803 - 807
  • [44] A Phase 2 Trial of Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic Adenocarcinoma
    Mamon, Harvey J.
    Niedzwiecki, Donna
    Hollis, Donna
    Tan, Benjamin R.
    Mayer, Robert J.
    Tepper, Joel E.
    Goldberg, Richard M.
    Blackstock, A. William
    Fuchs, Charles S.
    CANCER, 2011, 117 (12) : 2620 - 2628
  • [45] Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial
    Magrini, Stefano Maria
    Buglione, Michela
    Corvo, Renzo
    Pirtoli, Luigi
    Paiar, Fabiola
    Ponticelli, Pietro
    Petrucci, Alessia
    Bacigalupo, Almalina
    Crociani, Monica
    Lastrucci, Luciana
    Vecchio, Stefania
    Bonomo, Pierluigi
    Pasinetti, Nadia
    Triggiani, Luca
    Cavagnini, Roberta
    Costa, Loredana
    Tonoli, Sandro
    Maddalo, Marta
    Grisanti, Salvatore
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (05) : 427 - +
  • [46] Feasibility of induction docetaxel, cisplatin, 5-fluorouracil cetuximab (TPF-C) followed by concurrent cetuximab radiotherapy for locally advanced head and neck squamous cell carcinoma
    Charalambakis, Nikolaos
    Kouloulias, Vassilis
    Vaja, Helena
    Pectasides, Dimitrios
    Rampias, Theodoros
    Economopoulos, Theofanis
    Katsaounis, Panagiotis
    Siolos, Spiros
    Bartzi, Valentina
    Perisanidis, Christos
    Laschos, Konstantinos
    Maragoudakis, Pavlos
    Proikas, Konstantinos
    Papadimitriou, Nikolaos
    Papadogeorgakis, Nikolaos
    Georgopoulou, Helen
    Zygogianni, Anna
    Artopoulou, Ioli
    Pappa, Eleni
    Dimitriadis, George
    Psyrri, Amanda
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [47] Nimotuzumab with Intensity modulated radiation therapy (IMRT) in unresectable and platinum ineligible locally advanced head & neck cancer patients
    Srinivas, K. Satish
    Sundaram, R.
    Divyambika, C. V.
    Chaudhari, S.
    Pawar, D.
    ANNALS OF ONCOLOGY, 2017, 28
  • [48] Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study
    Schrijvers, D
    Van Herpen, C
    Kerger, J
    Joosens, E
    Van Laer, C
    Awada, A
    Van den Weyngaert, D
    Nguyen, H
    Le Bouder, C
    Castelijns, JA
    Kaanders, J
    De Mulder, P
    Vermorken, JB
    ANNALS OF ONCOLOGY, 2004, 15 (04) : 638 - 645
  • [49] Hypofractionated radiotherapy with concurrent 5-fluorouracil radiosensitisation for recurrent or locally advanced colorectal cancer - A phase II study
    Skarlatos, J
    Kosma, L
    Koukourakis, M
    Zambatis, C
    Kapsoritakis, A
    Mouder, N
    Yannakakis, D
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1996, 11 (05) : 206 - 210
  • [50] Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    H Katori
    M Tsukuda
    I Mochimatu
    J Ishitoya
    S Kawai
    Y Mikami
    H Matsuda
    Y Tanigaki
    C Horiuchi
    Y Ikeda
    T Taguchi
    M Ono
    T Yoshida
    S Hirose
    Y Sakuma
    K Yamamoto
    British Journal of Cancer, 2004, 90 : 348 - 352
12345